Accessibility Menu
Merck KGaA Stock Quote

Merck KGaA (OTC: MKKGY)

$26.85
(0.3%)
+0.09
Price as of October 23, 2025, 3:58 p.m. ET

KEY DATA POINTS

Current Price
$26.85
Daily Change
(0.3%) +$0.09
Day's Range
$26.56 - $26.89
Previous Close
$26.85
Open
$26.8
Beta
0.69
Volume
355,347
Average Volume
147,145
Market Cap
17.3B
Market Cap / Employee
$26.76M
52wk Range
$24.32 - $33.97
Revenue
-
Gross Margin
0.59%
Dividend Yield
1.87%
EPS
$1.43
CAPs Rating
-
Industry
Pharmaceuticals

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

Merck KGaA Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
MKKGY-19.97%-7.77%-1.6%+171%
S&P+14.5%+93.32%+14.09%+352%

Merck KGaA Company Info

Merck KGaA is a science and technology company, which engages in the manufacture of pharmaceutical and chemical products. It operates through the following sectors: Healthcare, Life Science, Performance Materials and Corporate and Other. The Healthcare sector discovers, develops, and produces prescription medicines used to treat cancer, multiple sclerosis, and infertility. The Life Science sector provides scientists with laboratory materials, technologies, and services. The Performance Materials sector offers specialty chemicals and materials for demanding applications. The firm offers pharma and biopharma manufacturing, pharmaceutical research, pharma quality control, and government and academic research services. The company was founded by Friedrich Jacob Merck in 1668 and is headquartered in Darmstadt, Germany.

Financial Health

General

Q2 2025YOY Change
Revenue$5.96B3.5%
Gross Profit$3.43B-1.3%
Gross Margin57.60%-2.8%
Market Cap$16.76B-21.8%
Market Cap / Employee$0.27M-23.0%
Employees63.2K1.6%
Net Income$742.98M14.1%
EBITDA$1.74B-12.1%

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

Q2 2025YOY Change
Net Cash$1.37B-52.4%
Accounts Receivable$5.12B8.9%
Inventory5.2K3.8%

Liabilities

Q2 2025YOY Change
Long Term Debt$7.39B-11.8%
Short Term Debt$3.64B16.1%

Ratios

Q2 2025YOY Change
Return On Assets5.71%0.4%
Return On Invested Capital8.51%0.6%

Cash Flow

Q2 2025YOY Change
Free Cash Flow$292.69M-50.1%
Operating Free Cash Flow$635.79M-31.2%

Valuation

MetricQ3 2024Q4 2024Q1 2025Q2 2025YoY Change
Price to Earnings26.2120.9519.6418.03-28.96%
Price to Book2.511.971.921.75-26.58%
Price to Sales3.372.752.602.43-23.89%
Price to Tangible Book Value5.313.783.822.95-50.49%
Price to Free Cash Flow TTM45.2531.2638.6145.91-4.19%
Enterprise Value to EBITDA45.3742.5039.0737.70-7.54%
Free Cash Flow Yield2.2%3.2%2.6%2.2%4.38%
Return on Equity9.5%9.9%9.7%9.8%2.66%
Total Debt$12.71B$10.67B$9.40B$11.04B-4.20%

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.